Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David M. Epstein currently holds 40,000 shares of Black Diamond Therapeutics, Inc. (BDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David M. Epstein has been a net seller of BDTX stock. They have purchased $0 and sold $1.7M worth of shares.
David M. Epstein's most recent insider trade was on Jun 10, 2026, when they sold 40,000 shares at $0.00 per share.
David M. Epstein serves as Executive at Black Diamond Therapeutics, Inc. (BDTX). They have executed 27 insider transactions totaling $1.7M over their tenure at the company.
David M. Epstein holds the position of Executive at Black Diamond Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
David M. Epstein has shown a selling trading pattern, with $0 in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David M. Epstein was on Jun 3, 2010, when they sold $564.0K worth of OSIP shares. This transaction involved 9,809 shares at $57.50 per share.
David M. Epstein currently owns 40,000 shares of Black Diamond Therapeutics, Inc. (BDTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David M. Epstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David M. Epstein has 27 Form 4 filings on record as an insider at Black Diamond Therapeutics, Inc..
Set alerts for David M. Epstein and 40,000+ other insiders.